Rejoyn: A Fundamental Change in How Clinicians Can Treat MDD Symptoms

Rejoyn was recently cleared by the FDA, making it the first prescription digital therapeutic for major depressive disorder.

Related Keywords

United States ,John Kraus ,Patient Health Questionnaire ,Psychiatric Times ,Depression Rating Scale ,Clinical Global Impression ,Faces Memory ,